Related Experiment Video
Updated: Aug 13, 2026
A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
[Permanent double-lumen central venous catheters--replacement for arteriovenous fistula]
Denijal Tulumović1, Mirza Atić, Mustafa Bazerdzanović
1Klinika za nefrologiju, urologiju, dijalizu i transplantaciju bubirega UKC Tuzla, Bosna i Hercegovina.
Insights
Permanent double lumen central venous catheters (PermCath) offer a secure vascular access for hemodialysis patients with inadequate arteriovenous fistulas. This study found PermCath to be a safe and effective option, even in cases of catheter-related infections with appropriate antibiotic treatment.
Area of Science:
- Nephrology
- Vascular Surgery
- Infectious Diseases
Context:
- Chronic hemodialysis necessitates reliable vascular access for patient well-being and treatment efficacy.
- Arteriovenous fistulas are the preferred access, but complications or inadequate development necessitate alternatives.
- Permanent central venous catheters (PermCath) are an option for patients lacking suitable arteriovenous access.
Purpose:
- To evaluate the safety and efficacy of permanent double lumen central venous catheters (PermCath) in patients undergoing chronic hemodialysis.
- To assess the outcomes of PermCath placement in patients with inadequate vascular access, including complication rates and infection management.
Summary:
- This study involved 35 chronic hemodialysis patients (8 male, 27 female, average age 56) who received PermCath placement, primarily in the internal jugular vein.
- Catheters were in place for an average of 233.55 days, with a notable complication rate of sepsis in four patients, successfully managed with antibiotics in two cases.
- Microbiological analysis identified various bacterial species, including Enterococcus, Pseudomonas, Acinetobacter, Enterobacter, and Staphylococcus.
Impact:
- PermCath provides a secure and viable vascular access option for hemodialysis patients when arteriovenous fistulas are insufficient or unavailable.
- Effective management strategies, including targeted antibiotic therapy, can mitigate risks associated with catheter-related infections.
- The findings support the use of PermCath as a bridge or alternative to arteriovenous fistulas, improving patient care in chronic kidney disease management.
Introduction:
The adequate vascular access in the patients on chronically hemodialysis treatment is very importance element in patient feel secure, and medical staff in hemodyalisis centre. The aim of this work is to examinee possibility of the use of permanent double lumen central venous catheter (PermCath) in patients with inadequate vascular access.
Patients And Method:
PermCath has been placed with local anesthesia in chirurgical room. Eight catheters was application in vena subclavia (three of them in links vena subclavia and six in right vena subclavia) and 26 in vena jugularis internal (for of them in links vena jugularis and 22 in right vena jugularis. The catheters were long 19 cm (26 catheters) and 23 cm (nine catheters). The catheters has been placed in 35 patients on chronically hemodialysis program, eight mean and 27 women, average age 56.03 +/- 16.52 (19 to 77 years). The causal chronically kidney disease has been diabetes mellitus in 12 (34.29%) patients, chronically pyelonephritis in eight (22.86%) patients, polycystic kidney disease in five (14.29%) patients, chronically glomerulonephritis in three (8.57%) patients and seven (20%) patients with other diseases.
Results:
The catheters has been placed average 233.55 +/- 303.58 days (9 to 1256 days). For three catheters have not registered wail the patients was from another hemodialysis centre. In four of patients were registered catheter sepsis episodes. In two of them catheter was treated with adequate doses of antibiotics since we have performed adequate and systemically antibiotics in lumen of catheter. The isolated bacteria from microbiological examination were: Enterococcus species and Pseudomonas species. Van catheter was isolated, and in microbiological examination from blood were registered Acinobacter species and Enterobacter species. A van patient past away and microbiological examination shown Staphylococcus species.
Conclusion:
PermCath is very security permanent vascular access in the patients with loss construction arteriovenous fistula. The catheter in the patients who has been not adequate arteriovenous fistula, and with adequate treatment he has exchange for arteriovenous fistula.
Related Concept Videos
01:25Hemodialysis I: Introduction
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
01:30Continuous Renal Replacement Therapy
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
01:21Cardiac Catheterization II: Right Heart Catheterization
01:29Venous Thrombosis III: Interprofessional Care